Pfizer-BioNTech’s Antiviral Pill For Treating COVID In Kids Has Entered New Trial Phase

Pfizer-BioNTech is moving into the next stages of development for a version of its COVID-19 antiviral pill that will be safe for children younger than 12 years of age.